Vasoactive intestinal peptide in the hamster seminal vesicle: distribution, binding sites and possible functions.
The presence and functional role of vasoactive intestinal peptide in the hamster seminal vesicle were studied by a combination of structural and functional approaches. The use of an immunofluorescence staining technique in both cryostat sections and whole-mount preparations revealed that vasoactive intestinal peptide-immunoreactive nerve fibres were mainly localized in the lamina propria of the mucosal layer. In double-stained preparations, vasoactive intestinal peptide immunoreactivity was found to be localized in nerves also containing acetylcholinesterase activity. At the ultrastructural level, the use of an immunogold staining method showed that vasoactive intestinal peptide immunoreactivity occurred in large granular vesicles (80-150 nm in diameter) in nerve varicosities which also contained small pleomorphic agranular vesicles. In order to evaluate the anatomical distribution of vasoactive intestinal peptide binding sites in the seminal vesicle, we have utilized an in vitro receptor autoradiographic technique. Vasoactive intestinal peptide binding sites were localized in the basal region of the secretory epithelium, in the muscle layer and in the wall of blood vessels. In vitro incorporation of [3H]L-leucine into protein by tissue slices revealed that vasoactive intestinal peptide (1 microM) significantly increases the amount of released protein. Vasoactive intestinal peptide (0.1-1 microM) did not affect the resting tension of the muscle but significantly inhibited the increase in muscle tension induced by carbachol. Atropine prevented the effect of carbachol, indicating that the latter is mediated by muscarinic receptors. Our results suggest that in the hamster seminal vesicle, vasoactive intestinal peptide is involved in the modulation of muscarinic function and in the control of secretion.
Pinho
M S
MS
Laboratory of Cell Biology, Gulbenkian Institute of Science, Oeiras, Portugal.
Sebastião
A M
AM
Rodrigues
G
G
Barroso
C P
CP
Ribeiro
J A
JA
Mata
L R
LR
Gulbenkian
S
S
D000110:Acetylcholinesterase / Q000032:analysis; D000818:Animals; D015415:Biomarkers; D006224:Cricetinae; D008297:Male; D008647:Mesocricetus / Q000033:anatomy & histology / Q000378:metabolism*; D009126:Muscle Relaxation / Q000187:drug effects; D009129:Muscle Tonus / Q000502:physiology; D009130:Muscle, Smooth / Q000502:physiology; D011976:Receptors, Muscarinic / Q000502:physiology; D018005:Receptors, Vasoactive Intestinal Peptide / Q000032:analysis*; D012636:Secretory Rate / Q000187:drug effects; D012669:Seminal Vesicles / Q000737:chemistry* / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000032:analysis* / Q000502:physiology
D015415:Biomarkers; D011976:Receptors, Muscarinic; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide; D000110:Acetylcholinesterase